目的探讨核素显像对缺血性心肌病（ICM）的诊断价值和疗效评价价值。
Objective: Investigate the values of radionuclide imaging in ischemic cardiomyopathy(ICM) patients' diagnosis and curative effects evaluating.
结论生脉注射液配合西医常规疗法治疗缺血性心肌病充血性心力衰竭疗效满意。
Conclusions Integration of shengmai injection and routine Western Medicine treatment can produce a satisfied effect on ischemic myocardial disease with congestive heart failure.
结论：静脉注射阿霉素可以诱导形成非缺血性心肌病模型，结果可靠，成功率高。
CONCLUSION: Intravenous injection of adriamycin can be used to induce a reliable rabbit model of non ischemic dilated cardiomyopathy with a high success rate.
方法：将2 1例缺血性心肌病和31例扩张型心肌病患者的超声检查结果进行比较分析。
Methods The results of 2D color Doppler were compared between 21 patients with ischemic cardiomyopathy and 31 patients with dilated cardiomyopathy.
结果：室壁局限性变薄及室壁节段性运动异常，主动脉瓣区退行性变是缺血性心肌病的超声特征。
Results Ischemic cardiomyopathy was echocardiographically characterized by the thinning of left ventricle region wall and abnormal motion and aortic regress.
结论：核素心肌灌注显像与门控心室显像联合评价对缺血性心肌病诊断治疗的价值优于单项检查。
Conclusion: the combine image of SPECT myocardial perfusion image and gating cardiac blood-pool image might have more value to the diagnosis of ischemic cardiomyopathy than each of them.
结论：经皮腔冠状动脉内移植骨髓干细胞治疗缺血性心肌病可行，术后能提高左室射血分数，心功能改善。
CONCLUSION: It is feasible to treat ischemic cardiomyopathy by percutaneous coronary transplantation of BMSCs, which can boost LVEF and improve cardiac function after transplantation.
目的评价经皮冠状动脉介入治疗(pci)对老年缺血性心肌病心功能不全的近期疗效及远期预后的影响。
Objective To investigate the effects of percutaneous coronary intervention (PCI) on the treatment and prognosis of heart failure derived from ischemic cardiomyopathy in aged patients.
有功能活性心肌干细胞的丢失或许可以作为慢性缺血性心肌病心功能进行性恶化和终末心力衰竭开始的标志。
The loss of functionally competent CSCs in chronic ischemic cardiomyopathy may underlie the progressive functional deterioration and the onset of terminal failure.
本研究为将来开发出一系列新的能特异性靶向心脏、用于治疗和诊断缺血性心肌病的方法打下了新的理论和技术基础。
Our findings have established the fundamental base in theory and technology for further tailor of the novel specific treatment and diagnosis methods in ischemic heart.
肥厚性心肌病与缺血性心脏病无关，但是50%的病例具有家族性并且与基因突变有关。突变基因一般为心脏收缩过程先关基因。
Hypertrophic cardiomyopathy is not related to ischemic heart disease but 50% of cases are familial and may be related to genetic mutations in genes encoding for cardiac contractile elements.
肥厚性心肌病与缺血性心脏病无关，但是50%的病例具有家族性并且与基因突变有关。突变基因一般为心脏收缩过程先关基因。
Hypertrophic cardiomyopathy is not related to ischemic heart disease but 50% of cases are familial and may be related to genetic mutations in genes encoding for cardiac contractile elements.
应用推荐